Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Licenses Axis-Shield's Rheumatoid Arthritis Assay

NEW YORK (GenomeWeb News) — Bio-Rad Laboratories today said it has licensed Axis-Shield’s early-detection rheumatoid arthritis test.
 
Bio-Rad said the Axis-Shield assay, which is based on anti-CCP antibodies, will run on its BioPlex 2200 system.
 
The BP2200 is an automated multiplexing system that works at a rate of 2,200 results per hour. The platform already holds several assays designed for other autoimmune diseases.
 
Financial terms of the agreement were not released.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.